Evaluation of the Metabolic Parameters in Women with Gestational Diabetes Mellitus after Delivery: A Comparative Study
The majority of women with GDM have clinical signs and symptoms that indicate a type 2 diabetes risk (T2D). T2D can be prevented or delayed, according to current data, by making significant lifestyle changes and taking drugs, particularly those that reduce insulin resistance. The obligatory clinical care step in the postpartum period is a glucose tolerance test to diagnose diabetes or assess diabetes risk. All patients should be closely monitored for signs of progressive -cell degeneration, such as rising glycemia. For this, a combination of fasting glucose and glycosylated haemoglobin tests is recommended. Monitoring should be done at least once a year. If glycemia is rising and/or impaired, this should be done on a regular basis. To reduce the risk of T2D, lifestyle changes are recommended. Breastfeeding is also very important for the infant’s substantial short- and long-term health benefits; encouraging and assisting breastfeeding mothers lowers the risk of later obesity and glucose intolerance.
Dr. Seema Singh
Department of Physiology, Era’s Lucknow Medical College and Hospital, Lucknow, India.
Dr. Nitin Ranjan Gupta
Department of Internal Medicine, Hind Institute of Medical Sciences and Research. Ataria, Mau, Sitapur, India.
View Book :- https://stm.bookpi.org/HMMS-V9/article/view/2239